Evofem Biosciences, Inc.
Evofem Biosciences, Inc.（EVFM）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
evfm · 股价预测 · 9 位分析师（近3月）· FMP · 更新于 2026年5月20日
分析师评级与共识
基于过去 3 个月内 9 位华尔街分析师
Buy
9 位分析师
共识
评级分布
12 个月目标价
High
$66.25
Consensus
$66.25
+883233.3% upside
Low
$66.25
Median: $66.25 · Last Close: $0.01
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.01 | ↑ 5.00% |
1-day model range: $0.01–$0.01. Peak: $0.01 (+5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · EVFM · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2022-10-13 | Stifel | Downgrade ↓ | Buy→Hold |
| 2022-08-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-07-15 | Morgan Stanley | Maintains | Underweight→Underweight |
| 2022-06-02 | Laidlaw & Co. | Maintains | Buy→Buy |
| 2022-05-25 | Piper Sandler | Maintains | Overweight→Overweight |
| 2022-05-11 | Morgan Stanley | Maintains | Underweight→Underweight |
| 2022-05-10 | Morgan Stanley | Maintains | Underweight→Underweight |
| 2022-04-12 | Morgan Stanley | Maintains | Underweight→Underweight |
| 2022-03-04 | Morgan Stanley | Maintains | Underweight→Underweight |
| 2021-11-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Evofem Biosciences, Inc. (EVFM) stock. Of the recent 25 rating actions, 0 were upgrades and 2 were downgrades. 9 analysts currently cover EVFM.
分析师推荐趋势
EVFM analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$33M
↓ 73.4% YoY
Revenue Next Year
$19M
↓ 44.1% YoY
EPS This Year
$-995.00
EPS Next Year
$-7.80
↓ 99.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast EVFM EPS of $-995.00 for the current fiscal year, based on estimates from 1 analysts. The EVFM revenue forecast is $33M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
EVFM 股价预测由两类独立数据源支撑：来自 9 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。EVFM 的共识目标价为 $66.25（+883233.3% 上行空间），分析师共识为 Buy。
EVFM 的短期预测（明日）为 $0.01（+5.00%）。
Evofem Biosciences, Inc. 在 OTC 上市，代码 EVFM。EVFM 在 2027 年的整体展望偏积极，在覆盖分析师中约 78% 对应 Buy 共识。
常见问题
EVFM 预测 · 8 个问题根据 9 位华尔街分析师，EVFM 的 12 个月平均目标价为 $66.25，最高 $66.25、最低 $66.25。若有图表，中位目标价可在上方查看。相对当前价 $0.01，隐含约 +883233.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.